WHO ICTRP trial

A clinical trial studying the safety and effectiveness of the study drug…

EUCTR2010-023648-34-BE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2010-023648-34-BE
Public title A clinical trial studying the safety and effectiveness of the study drug Anamorelin HCl for treating cachexia (weight loss and muscle mass loss) in patients with Non-Small Cell Lung Cancer
Scientific title Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer – Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients with NSCLC-C
Primary sponsor Helsinn Therapeutics (U.S.), Inc.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries France;United States;Hungary;Czech Republic;Slovenia;Canada;Poland;Spain;Belgium;Netherlands;Germany;Italy
Conditions Non-Small Cell Lung Cancer related Cachexia (NSCLC-C) MedDRA version: 14.1 Level: LLT Classification code 10002646 Term: Anorexia System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: LLT…
Interventions Product Name: Anamorelin HCl Pharmaceutical Form: Tablet INN or Proposed INN: Anamorelin HCl Current Sponsor code: Anamorelin HCl Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Pharmaceutical form…
Registration date Jun 16, 2011
Target size 477
Secondary IDs HT-ANAM-301
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations